Literature DB >> 20811317

A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.

Jennifer I Lim1, Christine Spee, David R Hinton.   

Abstract

PURPOSE: The purpose of this study was to first determine whether hypoxia-inducible factor-1α (HIF-1 α) was detectable in diabetic preretinal membranes and to compare the presence of HIF-1α in fibrovascular proliferative diabetic retinopathy membranes with nondiabetic, idiopathic, epiretinal membranes.
METHODS: Twelve patients with proliferative diabetic retinopathy membranes requiring pars plana vitrectomy and nine nondiabetic patients with idiopathic epiretinal membranes requiring pars plana vitrectomy underwent excision of these membranes. Immunohisto-chemical staining for the presence of HIF-1α was performed on the excised membranes. The degree of staining for HIF-1α (1+, 2+, and 3+ scale) and the cellular location of staining were determined for each specimen. Institutional Review Board approval and informed consent were obtained for all patients.
RESULTS: Eleven of 12 (92%) diabetic preretinal membranes were positive for HIF-1α, and most had intense (2+ to 3+) cytoplasmic staining with occasional focal nuclear positivity. Five of 9 (55%) nondiabetic epiretinal membranes were positive for HIF-1α with significantly weaker cytoplasmic staining (1+ to 2+) with occasional focal punctuate nuclear staining.
CONCLUSION: Hypoxia-inducible factor-1α is found more often and more intensely in diabetic preretinal membranes compared with nondiabetic idiopathic epiretinal membranes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811317      PMCID: PMC3690285          DOI: 10.1097/IAE.0b013e3181d6df09

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  20 in total

Review 1.  Regulation of angiogenesis by hypoxia: role of the HIF system.

Authors:  Christopher W Pugh; Peter J Ratcliffe
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 2.  The HIF pathway as a therapeutic target.

Authors:  Kirsty S Hewitson; Christopher J Schofield
Journal:  Drug Discov Today       Date:  2004-08-15       Impact factor: 7.851

3.  Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.

Authors:  S A Vinores; A I Youssri; J D Luna; Y S Chen; S Bhargave; M A Vinores; C L Schoenfeld; B Peng; C C Chan; W LaRochelle; W R Green; P A Campochiaro
Journal:  Histol Histopathol       Date:  1997-01       Impact factor: 2.303

4.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Authors:  Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 6.  HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs.

Authors:  Nathalie M Mazure; M Christiane Brahimi-Horn; Mélanie A Berta; Emmanuel Benizri; Rebecca L Bilton; Frédéric Dayan; Amandine Ginouvès; Edurne Berra; Jacques Pouysségur
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

7.  Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia.

Authors:  Walter J Lukiw; Anna Ottlecz; George Lambrou; Monika Grueninger; Joelle Finley; Hilary W Thompson; Nicolas G Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

8.  Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.

Authors:  Midori Yamakawa; Louis X Liu; Taro Date; Adam J Belanger; Karen A Vincent; Geoffrey Y Akita; Takayuki Kuriyama; Seng H Cheng; Richard J Gregory; Canwen Jiang
Journal:  Circ Res       Date:  2003-09-04       Impact factor: 17.367

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  David R Hinton; Christine Spee; Shikun He; Stephen Weitz; William Usinger; Laurie LaBree; Noelynn Oliver; Jennifer I Lim
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

View more
  20 in total

Review 1.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

Review 2.  Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia.

Authors:  Sergiu-Bogdan Catrina
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

3.  HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells.

Authors:  Jingqi Yan; Ziyan Zhang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2011-05-27       Impact factor: 9.261

4.  Survivin contributes to the progression of diabetic retinopathy through HIF-1α pathway.

Authors:  Ningning Liu; Ning Zhao; Lei Chen; Na Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 5.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

6.  Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.

Authors:  Ningning Liu; Lei Chen; Na Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 7.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

Review 8.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

Review 9.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

10.  Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke.

Authors:  Ziyan Zhang; Jingqi Yan; Honglian Shi
Journal:  Neurobiol Dis       Date:  2016-07-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.